Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
The company continues to show impressive growth in BELBUCA scripts and sales. Recently acquired Symproic also seems to be off to a good start in the hand of BioDelivery as well. The company is on its way to achieving cash flow positive status by the close of this year. Selling at less than one times the eventual annual sales management believes it can achieve with BELBUCA and Symprioc, the shares remain cheap.
Join the sharewise community
Get your free sharewise account now. Registration only takes a minute and gives you access to many different things, from personal watchlists to the ability to track your own predictions and interesting games.
Information about Cookies on sharewise.com
This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK".
More infos can be found in our Privacy declaration.
If you disagree this service is only available in very limited ways.
English
Deutsch
